- An extracellular loop 2 mutation P198A prevents the action of the antagonist RC3095 at the gastrin releasing peptide BB2 receptor
L Medeiros, D Nesheva, H Verli, R Roesler, N Holliday
- An investigation of the pharmacology of vortioxetine at human 5-HT3 receptors
A Roberts, G Grafton, S Larkin, S Butterworth, R Myerson, A Cooper, N Barnes
- A novel glucocorticoid-sensitising agent for the treatment of respiratory diseases
C Keenan, S Langenbach, M Li, Y Xia, T Harris, A Stewart
- Antidepressant prescription patterns in Ireland, 2004-2013: Is there a north/south divide?
J Kelly, W Garvey, B Hallahan
- Anti-diabetic drug metformin attenuates morphine tolerance and potentiates morphine effects in a mouse model of neuropathic pain
A Alsubayiel, E Middleton, E Battell, I Obara
- Antioxidant Tiron protects against Doxorubicin-Induced Cardiotoxicity
O Chiuzbaian, M Gharanei, C J Mee, H Maddock, E Hatch
- Anti-viral agent tenofovir induces mitochondrial damage and oxidative stress in hk-2 cells
R Murphy, D Rodriguez De Anda, R Stafford, K Brown, M Valentovic
- An updated systematic review and meta-analysis of the effect of medications with anticholinergic activity on the risk of dementia, mild cognitive impairment and cognitive decline
N Pieper, C Grossi, W-Y Chan, C Haroulis, Y Loke, G Savva, C Fox, T Smith, A Arthur, N Steel, I Maidment, P Myint, L Robinson, F Matthews, C Brayne, K Richardson
- A phase i study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (REVATIO©) in cardiac surgery: the REVAKI-1 study.
A Ring, T Morris, M Wozniak, N Sullo, W Dott, V Verheyden, T Kumar, N Brunskill, R Vaja, G Murphy
- A population pharmacokinetic model of co-amoxiclav in adult intensive care patients
D Lonsdale, K Kipper, C Barker, I Oldfield, B Philips, A Rhodes, E Baker, M Sharland, J Standing